264 related articles for article (PubMed ID: 34097307)
1. Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Chen B; Wu JX; Cheng SH; Wang LM; Rong WQ; Wu F; Wang SL; Jin J; Liu YP; Song YW; Ren H; Fang H; Tang Y; Li N; Li YX; Wang WH
Hepatology; 2021 Nov; 74(5):2595-2604. PubMed ID: 34097307
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels.
Wang WH; Wang Z; Wu JX; Zhang T; Rong WQ; Wang LM; Jin J; Wang SL; Song YW; Liu YP; Ren H; Fang H; Wang WQ; Liu XF; Yu ZH; Li YX
Liver Int; 2015 Dec; 35(12):2603-10. PubMed ID: 25939444
[TBL] [Abstract][Full Text] [Related]
3. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract][Full Text] [Related]
4. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.
Shi M; Guo RP; Lin XJ; Zhang YQ; Chen MS; Zhang CQ; Lau WY; Li JQ
Ann Surg; 2007 Jan; 245(1):36-43. PubMed ID: 17197963
[TBL] [Abstract][Full Text] [Related]
5. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
[TBL] [Abstract][Full Text] [Related]
6. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial.
Sun J; Yang L; Shi J; Liu C; Zhang X; Chai Z; Lau WY; Meng Y; Cheng SQ
Radiother Oncol; 2019 Nov; 140():20-25. PubMed ID: 31176205
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study.
Long L; Chen B; Wang H; Zhao Y; Wu F; Wang L; Rong W; Wu J; Li Y; Wang W
Radiother Oncol; 2023 Mar; 180():109462. PubMed ID: 36634853
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
13. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
[TBL] [Abstract][Full Text] [Related]
15. [Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma].
Xu L; Shi M; Zhang YQ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):47-9. PubMed ID: 16737621
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.
Zhong C; Guo RP; Li JQ; Shi M; Wei W; Chen MS; Zhang YQ
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1437-45. PubMed ID: 19408012
[TBL] [Abstract][Full Text] [Related]
17. Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.
Wu F; Chen B; Dong D; Rong W; Wang H; Wang L; Wang S; Jin J; Song Y; Liu Y; Fang H; Tang Y; Li N; Zhu X; Li Y; Wang W; Wu J
JAMA Surg; 2022 Dec; 157(12):1089-1096. PubMed ID: 36197682
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
19. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
